EDITY THERAPEUTICS LTD

General Data

Reg Number
516095270
Sector
Biomed
Established
2019
No. of Employees
20
Stage
R&D
Additional Funding
0

Technology

Immunotherapy

Targeted Customers

- Pharmaceutical companies - Biotechnology firms - Research institutions - Cancer treatment centers - Gene therapy developers

Management personnel

Michal Golan Mashiach - CEO & Co-Founder
[email protected].
Sharon Avkin-Nachum - VP, Technology
[email protected]

Contact information

Name
Website
https://edity-tx.com/
Country
Israel

Tags

BiotechnologyCancerGene TherapyLife SciencesMedTechTherapeutics

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023
R&D Fund
R&D Fund
2024
To the full list